Latest market data

Stock search

NEW YORK, April 29, 2011 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, announced today that it will report first quarter 2011 results on Thursday, May 5, 2011.

Management will host a conference call and simultaneous webcast to discuss the results of operations and provide an update on recent business developments at 4:30 P.M. ET on Thursday, May 5, 2011. Participants should call (877) 564-1219 (United States/Canada) or (973) 638-3429 (International) and request the SIGA call, or provide confirmation code 63752611. A live broadcast of the call will be available on the Company's website at www.siga.com under the 'Events & Presentations' tab in the Investor Relations section.

A replay of the call will be available approximately two hours after the call and will be accessible until 11:59 p.m. on Thursday, May 12, 2011. To listen to the replay, dial (800) 642-1687 (Domestic) or (706) 645-9291 (International) and enter the code 63752611. The webcast of the event will also be archived on the Company's website for one year under the 'Events & Presentations' tab in the Investor Relations section.

About SIGA Technologies, Inc.

SIGA Technologies is a pharmaceutical company specializing in the development and commercialization of therapeutic solutions for some of the most lethal disease causing pathogens in the world - smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. Our business is to discover, develop, manufacture and successfully commercialize drugs to prevent and treat these high priority threats. Our mission is to disarm dreaded viral diseases and create robust, modern biodefense countermeasures. For more information, please visit SIGA's web site at www.siga.com .